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ABSTRACT The fibroblast growth factor receptor 3 (FGFR3) is a protein belonging to the family of receptor tyro-
sine kinases. FGFR3 plays an important role in human skeletal development. Mutations in this protein, including 
Gly380Arg or Ala391Glu substitutions in the transmembrane (TM) region, can cause different disorders in bone 
development. The determination of the spatial structure of the FGFR3 TM domain in a normal protein and in a 
protein with single Gly380Arg and Ala391Glu mutations is essential in order to understand the mechanisms that 
control dimerization and signal transduction by receptor tyrosine kinases. The effective system of expression 
of eukaryotic genes in bacteria and the purification protocol for the production of milligram amounts of both 
normal TM fragments of FGFR3 and those with single pathogenic mutations Gly380Arg and Ala391Glu, as well 
as their 15N- and [15N, 13C]-isotope-labelled derivatives, were described. Each peptide was produced in Escherichia 
coli BL21(DE3)pLysS cells as a C-terminal extension of thioredoxin A. The purification protocol involved im-
mobilized metal affinity chromatography and cation- and anion-exchange chromatography, as well as the fusion 
protein cleavage with the light subunit of human enterokinase. The efficiency of the incorporation of target 
peptides into DPC/SDS and DPC/DPG micelles was confirmed using NMR spectroscopy. The described meth-
odology of  production of the native FGFR3 TM domain in norma and with single Gly380Arg and Ala391Glu 
mutations enables one to study their spatial structure using high-resolution heteronuclear NMR spectroscopy.
KEYWORDS membrane protein; FGFR; bacterial expression; purification; detergent solubilization; NMR.
ABBREVIATIONS FGFR - Fibroblast growth factor receptor family; FGFR3 - Fibroblast growth factor receptor 3; 
RTK - receptor tyrosine kinase; TM - transmembrane (domain of membrane protein); DPC — dodecylphospho-
choline; DPG — dodecylphosphoglycerol; SDS - sodium dodecyl sulfate; TFE — 2,2,2-trifluoroethanol.
INTRODUCTION
The fibroblast growth factor receptor 3 (FGFR3) be-
longs to the family of receptor tyrosine kinases (RTKs). 
This protein consists of an extracellular component 
with three immunoglobulin-like domains, a hydropho-
bic transmembrane (TM) domain, and an intracellular 
component with two tyrosine kinase domains. Specif-
ic ligands (fibroblast growth factors) and heparin are 
bound to the immunoglobulin-like domain of FGFR3, 
thus stabilizing the dimer complex consisting of two re-
ceptor molecules and providing  signal transduction in-
side the cell [1, 2]. FGFR3 plays an important role in the 
processes of human growth and development (both em-
bryonic/neonatal and that in an adult organism). Muta-
tions in this protein may result in various disorders in 
the development of connective tissues and skeleton [3–
5]. FGFR3 has also been known to participate in tumor 
formation [5, 6]. In particular, Gly380Arg and Ala391G-
lu mutations in the TM region of FGFR3 cause lethal 
dysplasia [7] and the Crouzon syndrome with acantho-
sis nigricans [8], respectively. The Ala391Glu mutation 
occurs both upon disorders in skeletal development 
and upon oncogenesis [6]. The Ala391Glu mutation is   
considered to stabilize FGFR3 dimerization in the cell 
membrane, resulting in uncontrollable signal transduc-
tion and the emergence of a pathology [9, 10]. However, 
the detailed mechanism of FGFR3 functioning has not 
been fully revealed. The approach that has been most 
frequently used in modern structural biology assumes 
the division of the membrane protein under study into 
components and studying the individual water-soluble 
components of the molecule and its TM regions [11–15]. 
It is extremely important to obtain a high-resolution 
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and that of the domain with Gly380Arg or Ala391Glu 
mutation to understand the mechanisms that control 
their dimerization and functioning, because these frag-
ments act as the linking units between the extracellular 
and intracellular RTK domains and directly participate 
in signal transduction inside the cell.
In this paper, an efficient system of gene expression 
and  purification protocol are described which enable 
one to produce preparative amounts of the FGFR3 TM 
fragment both in norma and with single Gly380Arg 
and Ala391Glu mutations, as well as their 15N- and [15N, 
13C]-labelled derivatives. The designed approach of 
producing TM peptides facilitates the study of their 
structure by high-resolution heteronuclear NMR spec-
troscopy.
EXPERIMENTAL
In this study, we used Escherichia coli strains XL-10-
Gold (Stratagene, United States) and BL21(DE3)pLysS 
(Stratagene, United States), plasmids pGEMEX-1 
(Promega, United States) and pGEMEX-1/TRX-TMS 
[16]. Oligonucleotides were synthesized by Evrogen   
(Russia). DNA was sequenced at the Inter-institute 
Center of Shared Use GENOME (Russia). The reagents 
purchased from CIL (United States) were used to intro-
duce the isotope labels 15N and 13C. The completely deu-
terized dodecylphosphoglycerol (DPG) was produced 
by enzymatic transphosphatidylation from completely 
deuterized dodecylphosphocholine (DPC) and glycerol 
in the presence of phospholipase D [17].
Gene cloning
Plasmid vectors for the expression of peptide genes as 
fusion proteins with thioredoxin A were constructed 
as described previously [12, 16–19]. The genes encod-
ing TM fragments of human FGFR3 (tmFGFR3) (amino 
acid residues 357–399 of the normal FGFR3 (tmFG-
FR3-nat) and 357–399 of FGFR3 with point mutations 
G380R (tmFGFR3-R), and A391E (tmFGFR3-E)) were 
assembled using six chemically synthesized oligonucle-
otides with partially overlapping nucleotide sequences. 
The codons used were optimized for the gene expres-
sion in E. coli cells. The restriction site BamHI and the 
sequence encoding the enterokinase recognition site 
were introduced into the 3’ and 5’ terminal primers, 
respectively. The same sequence was added to the 3’ 
terminus of the carrier protein gene (TRX) amplified 
using PCR from the pGEMEX-1/(TRX-TMS) vector 
[16]. The recombination of the TRX and tmFGFR3 genes 
was performed using PCR yielding TRX-tmFGFR3. 
The expression plasmids pGEMEX-1/(TRX-tmFG-
FR3) (Fig. 1B) were obtained by cloning TRX-tmFGFR3 
fragments treated with RsrII and BamHI restriction 
endonucleases into pGEMEX-1/(TRX-TMS) vectors 
linearized with the same proteases [16]. The validity 
of the nucleotide sequence within expression cassettes 
was confirmed by DNA sequencing on both strands.
Selection of cultivation conditions for 
the recombinant E. coli strain
Fusion protein genes were expressed in the E. coli cells 
BL21(DE3)pLysS. The cells were cultured in rich and 
minimal media; both chemical induction of protein syn-
thesis (TB and M9 media) and autoinduction [20] (me-
dia BYM5052, М5052, С750501’, or M50501, Table 1) 
being used. When selecting the optimal conditions for 
protein synthesis, an inducing agent, isopropyl-β-D-
thiogalactoside (IPTG), was added into the cell culture 
that was cultivated at 28°С and attained the optical 
density of ОD550 ~1.5 AU (TB medium) or ~0.6 AU (M9 
medium) up to the final concentrations of 1, 0.25, 0.05, 
0.01, and 0 mM. Cultivation was continued for 15 h at 
250 rpm and a temperature of 37°С; for 40 h (TB) or 60 h 
(M9) at 25°С; and 60 h (TB) or 72 h (M9) at 13°С. In the 
case of autoinduction media, the cells were cultivated 
at 300 rpm and a temperature of 18°С for 4 (BYM5052) 
А
B
Helix TrxA GS H6 GS EK tmFGFR3
TRX
T7 pr
RsrII TRX-tmFGFR3
BamHI
ter
Ampr
pGEMEX-1/ 
(TRX-tmFGFR3)
Fig. 1. Schematic representation of (A) TRX-tmFGFR3 
fusion proteins and (B) expression vectors. Helix – N-
terminal fragment of a membrane-active protein from 
Helicobacter pylori; TrxA – thioredoxin A of E.coli; GS – 
GlySerGlySerGly aminoacid sequence; H6 – hexahistidine 
sequence; EK – enterokinase light chain cleavage site; 
tmFGFR3 – target transmembrane peptide from FGFR3 
in norma or with Gly380Arg and Ala391Glu single point 
mutations; Ampr – ampicillin resistance gene.RESEARCH ARTICLES
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or 7 days (М5052, С750501’, or M50501). The optimal 
temperature, IPTG concentration, and cultivation time 
were determined using Tris-glycine SDS-PAGE elec-
trophoresis.
Gene expression
A M9 medium containing 0.0002% of yeast ex -
tract, 15NH4Cl, and [U-13С]-glucose (15N,13C-labelling) 
or 15NH4Cl and nonenriched glucose (15N-labeling) was 
used for the preparative obtaining of labelled proteins. 
In order to produce target fusion proteins, IPTG was 
added into the cell culture with OD600 ~ 0.6 AU (M9 
medium, isotope labelling) or 1.5 AU (TB medium, no 
labelling) up to a final concentration of 0.05 mM and 
the temperature was reduced from 28 to 13°С. The cells 
were cultivated at 250 rpm for 72 h. The cells were then 
harvested and stored at –20°C.
Target protein purification
The biomass obtained from 1  L of the culture was 
suspended in 50 ml of lysing buffer (50 mM Tris, pH 
8.0, 150 mM NaCl, 10 mM imidazole, 1% Triton X-100, 
0.2 mM phenylmethylsulfonyl fluoride), destroyed by 
ultrasound, centrifuged, and filtered through a mem- , and filtered through a mem-  and filtered through a mem-
brane (pore size 0.22 µm). The clarified lysate was ap-
plied to a column with Chelating Sepharose FF (Amer-
sham Bioscience, United States) preliminarily charged 
with Ni2+ and balanced with buffer A (50 mM Tris, pH 
8.0, 250 mM NaCl, 1% Triton Х-100) containing 10 mM 
imidazole. The resin was successively washed with buf-
fer A containing 10 mM imidazole and the same buffer 
containing 40 mM imidazole. The protein was eluted 
with buffer A containing 175 mM imidazole. The elu-
ate was diluted by a factor of 11 with buffer containing 
17 mM Tris, pH 8.0, 20 mM NaCl, and 1% Triton Х-100; 
then, the light chain of recombinant human enteroki-
nase was added [21] at a ratio of 25 units of enzyme per 
1 mg of TRX-tmFGFR3. The mixture was incubated for 
a night at room temperature and applied to a column 
with Chelating Sepharose FF balanced with buffer B, 
pH 8.0 (20 mM Tris, 40 mM NaCl, 1% Triton Х-100, 16 
mM imidazole). The unbound to the resin fraction was 
collected, pH was decreased to 4.55 using concentrated 
acetic acid, filtered through a membrane (pore size 0.22 
µm), and applied to a column with SP Sepharose FF 
(Amersham Bioscience, United States) balanced with 
buffer B, pH 4.55. After the fraction was applied, the 
resin was washed with the same buffer. The unbound 
to the resin fraction was collected, the pH was brought 
to 9.0 using NaOH, filtered through the membrane 
(pore size 0.22 µm), and applied to a column with Q 
Sepharose FF (Amersham Bioscience, United States) 
balanced with buffer C (20 mM Tris, рН 8.8, 1% Triton 
Х-100). The peptides were eluted with a linear NaCl 
gradient (0–1 M). After  incubation with a 10% trichlo-
roacetic acid (TCA) solution, the purified peptides were 
washed thrice with acetone and vacuum-dried. The pu-
rity and identity of the purified peptides to the target 
ones were confirmed by gel electrophoresis, MALDI 
mass spectroscopy (Daltonics Ultraflex II TOF/TOF, 
Bruker Daltonik, Germany), and NMR spectroscopy.
Solubilization of tmFGFR3 in a 
membrane-like environment
For preliminary folding into a helical conformation the 
specimens of isotope labelled tmFGFR3 were dissolved 
in a TFE/H2O (60/40) mixture with 2 mM tris(2-carbox-
yethyl)phosphine (TCEP) added in order to prevent the 
formation of nonspecific intermolecular disulfide bonds. 
Complete solubilization was achieved using 10 freeze (in 
liquid nitrogen)/thaw cycles. Homogenized specimens 
were obtained under ultrasonication (ultrasonic bath 
D-78224 Singen/Htw (Elma, Germany)) at the thaw 
stage in each cycle. The solubility and formation of 
the secondary structure of tmFGFR3 in the TFE/H2O 
mixture was controlled using 1H/15N-bestHSQC NMR 
spectra [22–24] by analyzing the signal width and sig-
nal dispersion. A solution of tmFGFR3 in TFE/H2O was 
Table 1. Composition of the auto-induction media used
Medium Studiera Na2HPO4 
(mM)
KH2PO4 
(mM)
Bacto 
trypton
Yeast 
extract, % Glycerol
Na2SO4, MgSO4, 
NH4Cl, Glucose, 
Lactose, Metals
BYM5052 ZYM-5052 + + 2% 1%  + +
М5052 N-5052 25 25 0.0002%  + +
C750501’ C-750501 + + 0.0002%  + +
M50501 C-750501 25 25 0.0002%  0.5% +
aAuto-induction medium that is taken as a basis.
Note: Components with a concentration  equal to the one used by Studier [20] are marked with a + sign.80 | ACTA NATURAE |  VOL. 3  № 3 (10)  2011
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mixed with the necessary amount of detergents and/
or lipids dissolved in TFE/H2O to obtain a detergent (li-
pid)/peptide ratio ranging from 120 to 40. The resulting 
mixture was lyophilized (ModulyoD-230 Freeze Dryer, 
Thermo, Canada) and dissolved in H2O/D2O (10/1) with 
10 freeze/thaw cycles (under ultrasonic action) to at-
tain protein homogeneity  and complete incorporation 
into detergent micelles or lipid bicelles. Heteronuclear 
NMR spectra of tmFGFR3 peptides incorporated into 
supramolecular complexes were obtained at 40°С, the 
pH varied from 3.5 to 6.5 on an AVANCE spectrome-
ter (Bruker, Germany) equipped with a cryogenically 
cooled high-sensitivity sensor, with a proton operating 
frequency of 700 MHz.
RESULTS AND DISCUSSION
System of tmFGFR3 gene expression
Peptides with a primary structure corresponding to the 
full-length  TM fragment of FGFR3 (tmFGFR3) with   
regions adjacent to the hydrophobic fragment (normal, 
tmFGFR3-nat and that with pathogenic point muta-
tions G380R (tmFGFR3-R) or A391E (tmFGFR3-E)) 
were studied in this work (Table 2). 
Due to the rapid proteolytic degradation of small 
peptides during their expression in bacterial cells, 
tmFGFR3 was obtained as  thioredoxin A  (TrxA) fu-
sion protein, as described earlier [12] (Fig. 1A). Six his-
tidine residues (H6), the recognition site of the human 
enterokinase light chain (EK), and mobile glycine-
rich fragments Gly-Ser-Gly-Ser-Gly (GS) on both 
sides from H6 were incorporated between the TrxA 
and tmFGFR3 fragments of the fusion protein. The 
highly specific enzyme EK selectively hydrolyzes the 
peptide bond located immediately after the recogni-
tion site (with the exception of the Lys-Pro bond). The 
amino acid sequence Helix is located at the N terminus 
of the fusion protein [12], facilitating the elimination 
of the toxicity of some TM peptides with respect to the 
host cell (no data are provided). The genes encoding the 
fusion proteins Helix-TrxA-GS-H6-GS-EK-tmFGFR3 
(hereinafter referred to as TRX-tmFGFR3) were in-
corporated into pGEMEX-1 plasmid vectors under 
the transcriptional control of the Т7 promoter yield-
ing pGEMEX-1/(TRX-tmFGFR3) expression vectors 
(Fig. 1B).
To produce proteins, E. coli BL21(DE3)pLysS cells 
were used, since an acceptable level of expression of 
target genes can be provided by these cells. When se-
lecting between autoinduction [20] and chemical induc-
tion, the choice in favor of the former is justified  by 
the absence of the necessity to add an inducing agent 
when the cell culture attains a certain optical density. 
The yields of the target proteins being comparable, 
the induction by IPTG wins out economically, since 
[U-13C]-glucose can be used as the only carbon source, 
instead of the more expensive [U-13C]-glycerol for 13C 
isotope labelling. 
The cultivation conditions at which  maximum ac-
cumulation of the target proteins was observed were 
determined by testing the media used for protein syn-
thesis induction using IPTG (TB and M9), as well as the 
auto-induction media proposed by FW Studier [20], 
taken with certain modifications (Table 1). The yeast ex-
tract was added to the media intended for the produc-
tion of isotope-labelled peptide derivatives (M5052 – to 
introduce 15N, and M9, С750501’, and M50501 – to in-
troduce [15N, 13С]) to obtain a concentration of 0.0002%. 
It was shown experimentally that this concentration 
of the yeast extract promotes the maximum increase 
in the yield of the target protein without having an ef-
fect on the 15N and 13С incorporation in the target pro-
tein. Considering the high cost of [U-13C]-glycerol, we 
carried out a number of experiments to determine the 
Table 2. Efficiency of the method of fusion proteins (TRX-tmFGFR3) and target peptides (tmFGFR3) production
TM-peptide
Molecular 
weight, 
kDa
Aminoacid sequence of a TM fragmenta
EKb, 
u/
mg
Yieldc, mg/ml
TRX-
tmFGFR3 tmFGFR3
tmFGFR3-nat 4.6 L357PAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLR399 25 40 6
tmFGFR3-R 4.7 L357PAEEELVEADEAGSVYAGILSYR380VGFFLFILVVAAVTLCRLR399 30 20 4
tmFGFR3-E 4.7 L357PAEEELVEADEAGSVYAGILSYGVGFFLFILVVE391AVTLCRLR399 30 50 7
a The putative TM domains are indicated as gray boxes. The point mutations Gly380Arg (tmFGFR3-R) and Ala391Glu 
(tmFGFR3-E) appear in bold.
b Activity of the enterokinase light chain  required to hydrolyze 1 mg of TRX-tmFGFR3 fusion proteins.
c The average yield (per 1 L of bacterial culture in M9 minimal media) of the fusion proteins (TRX-tmFGFR3) and purified 
peptides (tmFGFR3), including their 15N- and [15N-,13C]-labelled derivatives. The yields were estimated by the intensity 
of the Coomassie blue-stained bands in SDS-PAGE and by weighing pure, dried tmFGFR3 peptides.RESEARCH ARTICLES
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optimal glycerol concentration in the auto-induction 
medium at which maximum accumulation of the target 
product was observed. It appeared that a decrease in 
glycerol concentration by a factor of 1.5, along with a 
twofold fall in phosphate concentration in the culture 
medium (M50501 medium), either has no effect on the 
yield of the target products (tmFGFR3-nat and tmF-
GFR3-R) or enhances its accumulation (tmFGFR3-
E) (Fig. 2). This fact makes it possible to considerably 
reduce the cost of the production of [15N, 13С]-labelled 
preparations by using the auto-induction principle.
Bacterial cells transformed with the appropriate 
vector were cultivated at 18°С in the case of auto-in-
duction; or at 37, 25, and 13°С (after IPTG was added) 
when using chemical induction. The decrease in the 
cultivation temperature promotes maintenance of the 
protein in soluble form [12]. Thus, in the case of chemi-
cal induction, when cultivating cells both in rich (TB) 
and minimal (M9) media at high temperature (37°С), 
after adding IPTG, the fusion proteins mostly accu-
mulated within inclusion bodies. With the temperature 
decreasing to 25°С, protein solubility increased; the in-
clusion bodies contained half of the protein. At 13°С, all 
fusion proteins were observed mostly in soluble form 
(Figs. 2 and 3).
The dependence of the gene expression level on the 
cultivation temperature or concentration of the induc-
ing agent in case of chemical induction (1.0, 0.25, 0.05, 
and 0.01 mM IPTG) was assessed using SDS-PAGE 
electrophoresis. Based on the analysis results, a rich 
TB medium was used to produce target proteins (13°С 
after the induction) without incorporation of isotope 
labels. When using the M9 and M50501 media, the 
yield of fusion proteins appeared to be comparable 
(Fig. 2); therefore, the M9 medium (13°С after the in-
duction) was selected for the production of prepara-
tive amounts of isotope-labelled target proteins. A 
maximum yield of all TRX-tmFGFR3 or their 15N- or 
[15N, 13C]-labelled derivatives was attained at 0.05 mM 
IPTG.
Fusion protein purification
After cell lysis, fusion proteins were purified using im-
mobilized metal affinity chromatography (IMAC). In 
order to prevent the precipitation of target proteins, 
the non-ionic detergent Triton X-100 was used at this 
or subsequent purification stages. The purity of the 
protein preparations obtained by IMAC was at least 
80%. The molecular weights of the fusion proteins de-
termined on the basis of their electrophoretic mobility 
(SDS–PAGE, tricine buffer) (Fig. 4) were similar to the 
calculated values.
The fusion proteins TRX-tmFGFR3 purified by 
IMAC were cleaved using the human enterokinase 
tmFGFR3-nat  tmFGFR3-E  tmFGFR3-R 
1  2  3  4 1  2  3  4 1  2  3  4
Fig. 2. Efficiency of production of TRX-tmFGFR3 fusion 
proteins in M9 minimal salt and М5052, С750501’ and 
M50501 auto-induction media. Coomassie blue-stained 
14% Tris-glycine SDS-PAGE shows the fractionation of the 
lysate of whole cells producing TRX-tmFGFR3-nat, TRX-
tmFGFR3-E and TRX-tmFGFR3-R. Recombinant strains 
were grown in: 1 – M9 medium, 13°C after induction 
with 0.05 mM IPTG; 2 – M5052 auto-induction medium, 
18°C; 3 – M50501 auto-induction medium, 18°C; and 
4 – С750501’ auto-induction medium, 18°C. Equivalents 
of 20 μL of cell culture were loaded into each lane. Protein 
molecular weight markers: 116.0, 66.2, 45.0, 35.0, 25.0, 
18.4, and 14.4 kDa (top-down).
Fig. 3. Efficiency of production of TRX-tmFGFR3-E target 
fusion proteins in rich (TB) and minimal (M9) media de-
pending on growth temperature (37°C, 25°C, 13°C) after 
IPTG induction. Coomassie blue-stained 14% Tris-glycine 
SDS-PAGE analysis of TRX-tmFGFR3-E cell lysate (0.05 
mM IPTG). Protein molecular weight markers (kDa) are 
shown on the right. The arrow on the left indicates TRX-
tmFGFR3-E target fusion protein. 5 (TB) or 10 μL (M9) of 
cell culture were loaded into each lane. T — total cellular 
protein; S — soluble protein fraction.
116.0
66.2
45.0
35.0
25.0
18.4
14.4
37  25  13 37  25  13
TB M9
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kDa  1  2  3
27
17
14
6
TRX-tmFGFR3-nat
TRX
dimer tmFGFR3-nat
tmFGFR3-nat.
Fig. 4. Efficiency of purification of tmFGFR3-nat: 1 – puri-
fied fusion protein, 2 – products of enterokinase cleav-
age, 3 – purified tmFGFR3-nat. Arrows on the right 
indicate: TRX-tmFGFR3-nat fusion protein, TRX fusion 
partner, tmFGFR3-nat dimer and monomer compounds. 
Coomassie blue-stained 14% Tricine SDS-PAGE. Calcu-
lated molecular weights: TRX-tmFGFR3-nat – 19.6 kDa, 
tmFGFR3-nat – 4.6 kDa.
light chain (EK) [21] (Fig. 1A). When optimizing the re-
action conditions for each peptide, the efficiency of the 
subsequent purification studies was accounted for. An 
optimal composition of the reaction mixture was ob-
tained by diluting the fractions containing the fusion 
protein by a factor of 11 (see the EXPERIMENTAL 
section). EK (30 units per 1 mg of fusion protein TRX-
tmFGFR3) was used for complete isolation of tmFGFR3 
peptides from the partner protein (Fig. 4).
After the fusion protein had been cleaved for a 
night, IMAC was performed to remove the TRX frag-
ment and the residual amounts of fusion proteins from 
the reaction mixture. The concentration and addi-
tional purification of tmFGFR3-target peptides using 
two successive stages of cation-exchange and anion-
exchange chromatography at pH values ensuring the 
maximum charge and affinity of the target polypep-
tides towards ion-exchange resins were used to obtain 
protein preparations with a purity of at least 97%. The 
results of SDS–PAGE electrophoresis attest to the effi-
ciency of TRX-tmFGFR3-E hydrolysis and tmFGFR3-
E purification (Fig. 4). The data on the purification and 
efficiency of the proposed protocol for tmFGFR3-nat 
and tmFGFR3-R are identical. The electrophoretical 
mobility of tmFGFR3 corresponds to that of peptides 
mostly in monomeric conformations. The purity and 
correspondence of the purified peptides to the target 
tmFGFR3 were confirmed by mass spectroscopy analy-
sis (Fig. 5) and NMR spectroscopy.
As mentioned above, tmFGFR3 peptides were ob-
tained in the presence of Triton X-100. The high op-
tical density of the aqueous solution of Triton X-100 
impedes the use of the optical methods of analysis and 
determination of the secondary peptide’s structure in 
this detergent using CD spectroscopy. In the case of 
NMR spectroscopy (see below), even trace amounts  of 
Triton X-100 in the sample had a negative effect on 
the properties of the membrane-like environment that 
was used for structural studies, as well as the spatial 
structure of the protein. Peptides with Triton X-100 
were precipitated with TCA, followed by washing of 
the precipitate with cooled acetone, in order to effi-
ciently remove the detergent from the solution [12]. 
High efficiency of Triton X-100 removal from protein 
samples was confirmed by NMR spectroscopy. Using 
the procedure described, the yield of target proteins 
was brought up to 4–8 mg/l of the culture. The purity 
of the recombinant proteins and the degree of [15N, 13С]-
label incorporation were at least 97%.
Solubilization of tmFGFR3 in the 
membrane-like environment 
The selection of a medium imitating the surroundings 
of an object in the cell membrane is of exceptional sig-
nificance for a successful study of structure and func-
tions [23]. The composition of a membrane-like en-
vironment that would be optimal for NMR studies is 
determined by the following main parameters: size of 
supramolecular particles with tmFGFR3 incorporated 
into them; sample monodispersity; the absence of ag-
gregation and sample stability; implementation of the 
native helical conformation; and tmFGFR3 dimeriza-
tion. How closely the tmFGFR3 supramolecular com-
plexes in the selected membrane-like environment met 
these criteria was estimated using NMR spectroscopy. 
Both detergent micelles and lipid bicelles of different 
compositions were used as membrane-like media. The 
total quality of the samples in terms of the possibility of 
carrying out  further structural studies by NMR spec-
troscopy was assessed using two-dimensional spec-
tra 1H/15N-bestHSQC and 1H/15N-TROSY. The total 
number of allowed cross-peaks within the region of the 
NH-signals of glycerol residues, dispersion, broadening, 
and signal doubling were analyzed.
It should be noted that both zwitterionic and charged 
deuterized detergents, which provide a possibility of 
imitating partially charged cell membranes, are often 
required to perform structural studies of membrane 
proteins and peptides by NMR methods. Today, SDS 
is the only commercially available detergent that is 
completely deuterized and negatively charged. This RESEARCH ARTICLES
 VOL. 3  № 3 (10)  2011  | ACTA NATURAE | 83
detergent has no structural analogues among the phos-
pholipids that are components of biological membranes; 
therefore, the use of SDS to simulate membrane prop-
erties is not always reasonable. In this study, we made 
an attempt to use completely deuterized DPG synthe-
sized by us, in order to generate a partially negative 
charge on the micellar surface. The structure of the 
polar head of DPG is identical to that of phosphati-
dylglycerol, the main negatively charged phospholipid 
within bacterial membranes. The use of DPG allows to 
better simulate the properties of biological membranes 
as compared with SDS.
We selected tmFGFR3-nat solubilization conditions, 
which made it possible to study its spatial structure and 
dimerization. The best results upon solubilization of the 
tmFGFR3-nat peptide were obtained when using the 
mixed micelles of completely deuterized DPC/DPG 
(9/1 mol/mol) and DPC/SDS (9/1 mol/mol). The total 
number of peaks, good signal dispersion (being consid-
erably higher than the corresponding values for the 
peptide in random conformation, which attests to the 
formation of the secondary structure), and small line 
width in the 1H/15N-bestHSQC spectrum totally corre-
spond to its secondary structure and the hydrodynamic 
size expected based on the amino acid sequence of the 
peptide (Fig. 6). The presence of cross-peak doubling in 
1H/15N-bestHSQC spectra, as well as the dependence of 
the relative intensities in these doublets on the number 
of tmFGFR3-nat molecules incorporated in one micelle 
(Fig. 6), points to the successful determination of the 
tmFGFR3-nat dimerization conditions that are suit-
able for structural studies using heteronuclear NMR 
spectroscopy.
 
CONCLUSIONS
The elaborated system of gene expression and purifi-
cation protocol enables to produce recombinant trans-
membrane peptides tmFGFR3, including the isotope 
labelled derivatives to milligram amount, which are 
required for structural and functional studies. The 
relatively small size of the peptide complexes in the 
membrane-like environment attests to the possibil-
ity of obtaining the spatial structure of tmFGFR3-nat 
in dimeric state using high-resolution heteronuclear 
NMR spectroscopy [12, 24]. The conformation of the 
tmFGFR3-nat dimer was determined  recently, and the 
study of the processes accompanying the specific asso-
ciation of tmFGFR3-E and tmFGFR3-R is now under 
way. The proposed technology of recombinant peptides 
production will help better understand  the mechanism 
underlying the functioning, as well as signal transduc-
tion, with the participation of the FGFR3 receptor, as 
well as shed light on the molecular mechanisms of dif-
ferent disorders in human skeletal development, wich 
are directly associated with  mutations in the FGFR3 
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Fig. 5. Results of mass-spectroscopy analysis of the puri-
fied tmFGFR3-nat. The peaks in the spectrum correspond 
to tmFGFR3-nat monomer (m/z 4603) and dimer (m/z 
9209) compounds.
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Fig. 6. 1H/15N-bestHSQC NMR spectra of tmFGFR3-nat in 
DPC/DPG (left) and DPC/SDS (right) micelles. Tempera-
ture is 40°С, pH 5.7, and detergent/peptide molar ratio 
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